Literature DB >> 16703553

Choroidopathy with serous retinal detachment in a patient with polymyositis.

K Hotta1.   

Abstract

PURPOSE: The authors report a unique case of multifocal choroidopathy in association with polymyositis.
METHODS: The clinical presentation, laser treatment, and subsequent change in ocular findings are described.
RESULTS: A 65-year-old Japanese man with polymyositis experienced mid acute vision impairment in both eyes during systemic corticosteroid treatment for interstitial pneumonia. Fundus examination revealed a gray-white subretinal exudate with serous retinal detachment. Angiographic examination disclosed partial dilatation of the choroidal vein at the posterior pole and dye leakage points in the retinal pigment epithelium. The patient's left eye developed bullous retinal detachment and multi focal choroidal nodules at the posterior pole during the period of tapering of oral corticosteroid administration. Retinal burns were applied to the dye leakage points in the right eye using an argon laser. Vision in the right eye showed rapid recovery due to regression of the serous retinal detachment. However, in the left eye without retinal burns visual acuity decreased to light perception only even after regression of the bullous retinal detachment and choroidopathy.
CONCLUSIONS: In serous retinal detachment with choroidopathy associated with polymyositis, laser photocoagulation at leakage points may be useful for rapid restoration of vision and for the prevention of permanent severe vision loss.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703553     DOI: 10.1177/112067210601600220

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  1 in total

Review 1.  Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.

Authors:  Raul E Ruiz-Lozano; Fabiola Velazquez-Valenzuela; Mariana Roman-Zamudio; Salma K Andrade-Leal; Alejandro Rodriguez-Garcia
Journal:  Rheumatol Int       Date:  2021-10-21       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.